By
Drug Target Review2024-01-04T12:00:43
Researchers have developed a new PROTAC that activates the protein degradation system and binds to a previously inaccessible ligase.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-13T10:14:00Z
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-02-23T14:02:18
Sponsored by bit.bio
2024-02-08T11:07:39
Sponsored by Samplix ApS
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud